NASDAQ:MOTS - Motus GI Stock Price, Price Target & More

$4.34 -0.01 (-0.23 %)
(As of 04/23/2018 04:00 PM ET)
Previous Close$4.35
Today's Range$4.30 - $4.37
52-Week Range$3.75 - $5.30
Volume10,677 shs
Average Volume40,006 shs
Market Capitalization$67.75 million
P/E Ratio-3.36
Dividend YieldN/A
BetaN/A

About Motus GI (NASDAQ:MOTS)

Motus GI Holdings, Inc., a medical technology company, focuses on the development and commercialization of the Pure-Vu System. Its Pure-Vu System is designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company's Pure-Vu System improves colonoscopy experience for physicians, patients, and payers by diminishing the dependency on pre-procedural preparations. The company is based in Tirat Carmel, Israel.

Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MOTS
CUSIPN/A
Phone954-541-8000

Debt

Debt-to-Equity RatioN/A
Current Ratio4.18%
Quick Ratio4.18%

Price-To-Earnings

Trailing P/E Ratio-3.36
Forward P/E Ratio-4.30
P/E GrowthN/A

Sales & Book Value

Annual Sales$10,000.00
Price / Sales6,757.38
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees39
Outstanding Shares15,570,000

How to Become a New Pot Stock Millionaire

Motus GI (NASDAQ:MOTS) Frequently Asked Questions

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

What price target have analysts set for MOTS?

2 brokerages have issued 12 month price targets for Motus GI's shares. Their forecasts range from $7.00 to $7.00. On average, they anticipate Motus GI's share price to reach $7.00 in the next year. View Analyst Ratings for Motus GI.

Who are some of Motus GI's key competitors?

Who are Motus GI's key executives?

Motus GI's management team includes the folowing people:
  • Mr. Mark Pomeranz, CEO & Director (Age 56)
  • Mr. Todd Van Emburgh, Pres
  • Mr. Andrew Lawrence Taylor, CFO & Principal Accounting Officer (Age 46)
  • Ms. Hagit Ephrath, VP Health Economics, Regulatory & Clinical Affairs
  • Gil Balog, Gen. Mang. of Israel

When did Motus GI IPO?

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

When did Motus GI's quiet period expire?

Motus GI's quiet period expired on Monday, March 26th. Motus GI had issued 3,500,000 shares in its IPO on February 14th. The total size of the offering was $17,500,000 based on an initial share price of $5.00. During Motus GI's quiet period, insiders and any underwriters that worked on the IPO were prevented from issuing any research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Has Motus GI been receiving favorable news coverage?

Media headlines about MOTS stock have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Motus GI earned a media sentiment score of 0.07 on Accern's scale. They also gave media headlines about the company an impact score of 46.97 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $4.34.

How big of a company is Motus GI?

Motus GI has a market capitalization of $67.75 million and generates $10,000.00 in revenue each year. The company earns $-13,200,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis. Motus GI employs 39 workers across the globe.

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD Suite 310, FT. LAUDERDALE FL, 33301. The company can be reached via phone at 954-541-8000 or via email at [email protected]


MarketBeat Community Rating for Motus GI (MOTS)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  11 (Vote Outperform)
Underperform Votes:  9 (Vote Underperform)
Total Votes:  20
MarketBeat's community ratings are surveys of what our community members think about Motus GI and other stocks. Vote "Outperform" if you believe MOTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MOTS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Motus GI (NASDAQ:MOTS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Motus GI in the last 12 months. Their average twelve-month price target is $7.00, suggesting that the stock has a possible upside of 61.29%. The high price target for MOTS is $7.00 and the low price target for MOTS is $7.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.00$7.00N/AN/A
Price Target Upside: 61.29% upside41.41% upsideN/AN/A

Motus GI (NASDAQ:MOTS) Consensus Price Target History

Price Target History for Motus GI (NASDAQ:MOTS)

Motus GI (NASDAQ:MOTS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/12/2018OppenheimerInitiated CoverageOutperform$7.00HighView Rating Details
3/11/2018Piper JaffrayInitiated CoverageOverweight$7.00HighView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Dividends

Motus GI (NASDAQ:MOTS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Motus GI (NASDAQ MOTS) Insider Trading and Institutional Ownership History

Insider Trading History for Motus GI (NASDAQ:MOTS)

Motus GI (NASDAQ MOTS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/16/2018Andrew Lawrence TaylorCFOBuy2,000$5.00$10,000.00View SEC Filing  
2/16/2018David P HochmanChairmanBuy115,000$5.00$575,000.00View SEC Filing  
2/16/2018Gary J PrudenDirectorBuy50,000$5.00$250,000.00View SEC Filing  
2/16/2018Life Sciences Maste PerceptiveMajor ShareholderBuy1,000,000$5.00$5,000,000.00View SEC Filing  
2/16/2018Mark PomeranzCEOBuy8,000$5.00$40,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Motus GI (NASDAQ MOTS) News Headlines

Source:
DateHeadline
Motus GI Bolsters Medical Advisory Board with Appointment of Seth A. Gross, MD, FACG, FASGE, AGAFMotus GI Bolsters Medical Advisory Board with Appointment of Seth A. Gross, MD, FACG, FASGE, AGAF
finance.yahoo.com - April 16 at 3:19 PM
Motus GI Announces 2017 Financial Results and Provides Business OutlookMotus GI Announces 2017 Financial Results and Provides Business Outlook
finance.yahoo.com - April 6 at 6:46 AM
ValuEngine Lowers Motus GI (MOTS) to SellValuEngine Lowers Motus GI (MOTS) to Sell
www.americanbankingnews.com - April 3 at 12:11 PM
Motus GI Expands Intellectual Property Portfolio with New U.S. Patent Issuance for the Pure-Vu® SystemMotus GI Expands Intellectual Property Portfolio with New U.S. Patent Issuance for the Pure-Vu® System
finance.yahoo.com - March 27 at 3:18 PM
Motus GI Holdings Incs (MOTS) Quiet Period Set To End  on March 26thMotus GI Holdings Inc's (MOTS) Quiet Period Set To End on March 26th
www.americanbankingnews.com - March 19 at 1:23 AM
Analysts Issue Forecasts for Motus GI Holdings Incs Q1 2018 Earnings (MOTS)Analysts Issue Forecasts for Motus GI Holdings Inc's Q1 2018 Earnings (MOTS)
www.americanbankingnews.com - March 14 at 7:20 AM
Motus GI to Present at the Oppenheimer 28th Annual Healthcare ConferenceMotus GI to Present at the Oppenheimer 28th Annual Healthcare Conference
finance.yahoo.com - March 13 at 3:19 PM
Motus GI (MOTS) Research Coverage Started at OppenheimerMotus GI (MOTS) Research Coverage Started at Oppenheimer
www.americanbankingnews.com - March 12 at 11:26 AM
Piper Jaffray Companies Initiates Coverage on Motus GI (MOTS)Piper Jaffray Companies Initiates Coverage on Motus GI (MOTS)
www.americanbankingnews.com - March 11 at 8:18 PM
BRIEF-Motus GI Receives CE Mark Approval For The Pure-Vu SystemBRIEF-Motus GI Receives CE Mark Approval For The Pure-Vu System
www.reuters.com - February 27 at 3:16 PM
Motus GI Receives CE Mark Approval for the Pure-Vu® SystemMotus GI Receives CE Mark Approval for the Pure-Vu® System
finance.yahoo.com - February 27 at 3:16 PM
IPO News This Week: Holiday Doldrums ContinueIPO News This Week: Holiday Doldrums Continue
247wallst.com - February 25 at 3:15 PM
Insider Buying: Motus GI Holdings Inc (MOTS) Major Shareholder Purchases 1,000,000 Shares of StockInsider Buying: Motus GI Holdings Inc (MOTS) Major Shareholder Purchases 1,000,000 Shares of Stock
www.americanbankingnews.com - February 21 at 6:12 PM
Motus GI Holdings Inc (MOTS) Chairman David P. Hochman Purchases 115,000 SharesMotus GI Holdings Inc (MOTS) Chairman David P. Hochman Purchases 115,000 Shares
www.americanbankingnews.com - February 21 at 12:31 PM
Insider Buying: Motus GI Holdings Inc (MOTS) CEO Acquires 8,000 Shares of StockInsider Buying: Motus GI Holdings Inc (MOTS) CEO Acquires 8,000 Shares of Stock
www.americanbankingnews.com - February 21 at 9:14 AM
Insider Buying: Motus GI Holdings Inc (MOTS) Director Buys 50,000 Shares of StockInsider Buying: Motus GI Holdings Inc (MOTS) Director Buys 50,000 Shares of Stock
www.americanbankingnews.com - February 21 at 9:14 AM
Motus GI Holdings Plans $26 Million IPO for February 9th (MOTS)Motus GI Holdings Plans $26 Million IPO for February 9th (MOTS)
www.americanbankingnews.com - February 5 at 1:16 AM

SEC Filings

Motus GI (NASDAQ:MOTS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Motus GI (NASDAQ MOTS) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.